Weinan Jiang

Weinan Jiang

Auto-generated profile, based on publicly available information

Weinan Jiang

Suzhou Institute of Biomedical Engineering and Technology

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Min ZhouMin Zhou
Min Zhou
YQYuxin Qian
Yuxin Qian
JXJiayang Xie
Jiayang Xie
WZWenjing Zhang
Wenjing Zhang
WJWeinan Jiang
Weinan Jiang
Runhui LiuRunhui Liu
Runhui Liu

19 February 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
WJWeinan Jiang
Weinan Jiang
Min ZhouMin Zhou
Min Zhou
ZCZihao Cong
Zihao Cong
JXJiayang Xie
Jiayang Xie
WZWenjing Zhang
Wenjing Zhang
Runhui LiuRunhui Liu
Runhui Liu

15 November 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
WJWeinan Jiang
Weinan Jiang
Min ZhouMin Zhou
Min Zhou
SCSheng Chen
Sheng Chen
JXJiayang Xie
Jiayang Xie
MCMinzhang Chen
Minzhang Chen
Runhui LiuRunhui Liu
Runhui Liu

10 May 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Yueming WuYueming Wu
Yueming Wu
WJWeinan Jiang
Weinan Jiang
ZCZihao Cong
Zihao Cong
KCKang Chen
Kang Chen
YSYunrui She
Yunrui She
Runhui LiuRunhui Liu
Runhui Liu


19 November 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
WJWeinan Jiang
Weinan Jiang
XXXimian Xiao
Ximian Xiao
Yueming WuYueming Wu
Yueming Wu
WZWeiwei Zhang
Weiwei Zhang
ZCZihao Cong
Zihao Cong
Runhui LiuRunhui Liu
Runhui Liu
Multidrug resistant (MDR) Pseudomonas aeruginosa has caused serious nosocomial infections owing to its high intrinsic resistance and ease of acquiring resistance to common antibiotics. There is an urgent need to develop antimicrobial agents against MDR Pseudomonas aeruginosa. Here we report a 27-mer peptide polymer 90 : 10 DLL : BLG, as a synthetic mimic of a host defense peptide, that displayed potent in vitro and in vivo activities against multiple strains of clinically isolated MDR Pseudomonas aeruginosa, performing even better than antibiotics within our study. This peptide polymer also showed negligible hemolysis and low cytotoxicity, as well as quick bacterial killing efficacy. The structural diversity of peptide polymers, their easy synthesis from lithium hexamethyldisilazide-initiated fast N-carboxyanhydride polymerization, and the excellent reproducibility of their chemical structure and biological profiles altogether suggested great potential for antimicrobial applications of peptide polymers as synthetic mimics of host defense peptides.